A composite nanoemulsion, its preparation method and application
By preparing and applying composite nanoemulsions, the problem of lack of effective prevention and treatment of duck hepatitis virus was solved, achieving effective protection of ducklings and reducing the mortality rate of duck hepatitis A virus infection of serum type 3.
Patent Information
- Application Number
- CN202311730060.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-12-15
- Publication Date
- 2026-11-10
- Estimated Expiration
- 2043-12-15
AI Technical Summary
There is a lack of effective methods for the prevention and treatment of duck hepatitis virus in the current technology, especially the problems of attenuated vaccines with the risk of virulence reversion and vaccine immunization failure, and there is no effective treatment for duck hepatitis virus.
A composite nanoemulsion was prepared by mixing arachidonic acid oil, glyceryl tartrate, poloxamer 188, and ethylparaben to form an oil phase and an aqueous phase. The composite nanoemulsion with a particle size of 66.1 ± 15.63 nm was prepared by high-speed shearing and high-pressure homogenization. The nanoemulsion was then added to the drinking water or feed of ducks to prevent and treat duck viral hepatitis.
This composite nanoemulsion significantly reduced the mortality rate of ducklings, especially its protective effect against duck hepatitis A virus type 3 infection, with the mortality rate decreasing from 70% to 30% 96 hours after challenge.
Smart Images

Figure CN117530370B_ABST
Abstract
Description
Technical Field
[0001] This invention belongs to the field of feed additives and livestock disease treatment technology, specifically relating to a composite nanoemulsion, its preparation method, and its application. Background Technology
[0002] Duck viral hepatitis, caused by duck hepatitis virus (DHV), is a rapidly spreading and highly lethal viral disease in ducklings, causing significant economic losses to the duck farming industry. After infection, ducklings exhibit neurological symptoms such as depression, loss of appetite, generalized convulsions, and opisthotonus. Pathological examination primarily reveals hepatomegaly and hemorrhage. Currently, prevention and control mainly rely on attenuated live vaccines, but there is a risk of virulence reversion, and with the emergence of DHV variants, cases of vaccine failure occur frequently.
[0003] There is currently no effective treatment for duck hepatitis virus (DHV). Therefore, it is essential to develop a feed additive that can prevent and treat DHV. Summary of the Invention
[0004] The purpose of this section is to outline some aspects of embodiments of the present invention and to briefly describe some preferred embodiments. Simplifications or omissions may be made in this section, as well as in the abstract and title of this application, to avoid obscuring the purpose of these documents; however, such simplifications or omissions should not be construed as limiting the scope of the invention.
[0005] As one aspect of the present invention, the present invention provides the application of a composite nanoemulsion in the preparation of a feed additive for treating viral hepatitis in poultry or pets, wherein: the composite nanoemulsion is composed of the following components in parts by mass.
[0006]
[0007]
[0008] As a preferred embodiment of the application described in this invention: the treatment of viral hepatitis in poultry or pets includes duck viral hepatitis caused by duck hepatitis A virus of serum type III.
[0009] As a preferred embodiment of the application described in this invention: the composite nanoemulsion comprises, by mass parts, the following components.
[0010]
[0011] As a preferred embodiment of the application described in this invention: the arachidonic acid oil is obtained by filtering, pressing, drying, extracting and refining the mycelium obtained from the cultivation of *Morchella esculenta*, wherein the arachidonic acid content is ≥40%.
[0012] As a preferred embodiment of the application described in this invention, the poloxamer includes poloxamer 188.
[0013] As a preferred embodiment of the application described in this invention, the preparation method of the composite nanoemulsion includes: mixing arachidonic acid oil and glyceryl tartrate to form an oil phase and heating it; dissolving poloxamer in water and heating it; adding ethylparaben and stirring evenly to form an aqueous phase; mixing the oil phase and the aqueous phase; high-speed shearing; and high-pressure homogenization to obtain the composite nanoemulsion.
[0014] As a preferred embodiment of the application described in this invention, the preparation method of the composite nanoemulsion includes: mixing arachidonic acid oil and glyceryl tartrate to form an oil phase and heating it in a water bath to 40-80°C; then dissolving poloxamer in water and heating it in a water bath to 40-80°C, adding ethylparaben, stirring evenly to form an aqueous phase, mixing the oil phase and the aqueous phase, performing high-speed shearing and high-pressure homogenization, with the high-pressure homogenization pressure being 300-700 bar, to obtain the composite nanoemulsion.
[0015] As a preferred embodiment of the application described in this invention, the composite nanoemulsion is added to drinking water or feed at a mass content of 9-30%.
[0016] This invention also provides a composite nanoemulsion: composed of the following components in parts by mass,
[0017]
[0018] The present invention also provides a method for preparing the composite nanoemulsion: comprising the following steps: mixing arachidonic acid oil and glyceryl tartrate to form an oil phase and heating in a water bath to 50-60°C; dissolving poloxamer in water and heating in a water bath to 50-60°C; adding ethylparaben and stirring evenly to form an aqueous phase; mixing the oil phase and the aqueous phase; high-speed shearing for 5 minutes at a shearing speed of 15000 rpm; high-pressure homogenization at a pressure of 300-700 bar to obtain the composite nanoemulsion.
[0019] Beneficial effects of the present invention: During the experimental process, it was unexpectedly discovered that the prepared composite nanoemulsion can alleviate mortality in ducklings caused by DHAV-3 (diabetic hepatitis A virus type 3) infection. This invention is the first to discover that the prepared composite nanoemulsion can be added to duck diets as a feed or drinking water additive for the prevention and treatment of duck viral hepatitis. Attached Figure Description
[0020] To more clearly illustrate the technical solutions of the embodiments of the present invention, the drawings used in the description of the embodiments will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For those skilled in the art, other drawings can be obtained based on these drawings without creative effort. Wherein:
[0021] Figure 1 The appearance of the composite nanoemulsion.
[0022] Figure 2 This is a particle size distribution chart of the nanoemulsion particles.
[0023] Figure 3 To investigate the protective effect of nanoemulsion against ducklings infected with serum type III duck hepatitis A virus. Detailed Implementation
[0024] To make the above-mentioned objectives, features and advantages of the present invention more apparent and understandable, the specific embodiments of the present invention will be described in detail below with reference to specific examples.
[0025] Example 1:
[0026] Composite nanoemulsion formulation
[0027] Component Name Added amount Arachidonic acid oil 62.5g Trisuccinate 75g Polosham 188 10g Ethylparaben 1g water Fill to 1L
[0028] Preparation method of composite nanoemulsion: Arachidonic acid oil (Zhengzhou Sanhe Food Additives Co., Ltd., product number hss001, 40% arachidonic acid) and glyceryl tartrate were mixed to form an oil phase and heated to 60°C in a water bath; then poloxamer 188 was dissolved in water and heated to 60°C in a water bath, ethylparaben was added, and the mixture was stirred evenly to form an aqueous phase. The oil phase and the aqueous phase were mixed and subjected to high-speed shearing for 5 minutes at a shearing speed of 15000 rpm to obtain a coarse dispersion. The coarse dispersion was homogenized under high pressure at a pressure of 500 bar to obtain the composite nanoemulsion.
[0029] The prepared composite nanoemulsion was milky white in appearance, and the pH of the composite nanoemulsion was measured to be 4.76, with a particle size of 66.1 ± 15.63 nm. Figure 1 It has the appearance of a composite nanoemulsion. Figure 2 This is a particle size distribution chart of the nanoemulsion particles.
[0030] Example 2:
[0031] Composite nanoemulsion reduces mortality in ducklings infected with duck hepatitis virus:
[0032] Materials: 1-day-old healthy Cherry Valley ducklings, and the composite nanoemulsion prepared in Example 1 (diluted in drinking water at a mass ratio of 9:1000).
[0033] Methods: 180 ducklings were randomly divided into three groups: control group (Con), challenge group (DHV), and nanoemulsion group (LAA). Each group had six replicates, with ten ducklings per replicate. Ducklings in the control group (Con) and challenge group (DHV) drank normal water, while ducklings in the nanoemulsion group (LAA) drank water containing the composite nanoemulsion prepared in Example 1 (diluted to water at a mass ratio of 9:1000). After seven days of normal feeding, DHV challenge was performed on day eight. The challenge group (DHV) and nanoemulsion group (LAA) were intramuscularly injected with 0.2 mL of serum type III duck hepatitis A virus DHAV-3 (1×10⁻⁶). 6.2 ELD 50 / mL). Observe the mortality of ducklings 96 hours after the virus challenge and collect data.
[0034] Figure 3 The protective effect of nanoemulsion against ducklings infected with serum type 3 duck hepatitis A virus was studied. Figure 3 It can be seen that the mortality rate of the challenge group (DHV) was 70% 96 hours after challenge. The mortality rate of the nanoemulsion group (LAA) was 30% 96 hours after challenge. The composite nanoemulsion (diluted at a ratio of 9:1000) can alleviate the mortality of ducklings caused by DHAV-3 infection.
[0035] It should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention and are not intended to limit it. Although the present invention has been described in detail with reference to preferred embodiments, those skilled in the art should understand that modifications or equivalent substitutions can be made to the technical solutions of the present invention without departing from the spirit and scope of the technical solutions of the present invention, and all such modifications or substitutions should be covered within the scope of the claims of the present invention.
Claims
1. The application of a composite nanoemulsion in the preparation of feed additives for treating viral hepatitis in poultry or pets, characterized in that: The composite nanoemulsion, by mass parts, consists of the following components. Arachidonic acid oil 62.5 parts, 75 parts of tributyric acid glyceride 10 portions of Polosham 1 part of ethylparaben Water level should be reduced to 1000 portions. The treatment for viral hepatitis in poultry or pets is duck viral hepatitis caused by serological type III duck hepatitis A virus; the composite nanoemulsion can alleviate duckling mortality caused by serological type III duck hepatitis A virus infection; The arachidonic acid oil is obtained by filtering, pressing, drying, extracting and refining the mycelium obtained by fermentation culture of *Morchella alpineensis*, wherein the arachidonic acid content is ≥40% by mass. The preparation method of the composite nanoemulsion includes: mixing arachidonic acid oil and glyceryl tartrate to form an oil phase and heating it in a water bath to 40-80°C; then dissolving poloxamer in water and heating it in a water bath to 40-80°C, adding ethylparaben, stirring evenly to form an aqueous phase, mixing the oil phase and the aqueous phase, high-speed shearing, and high-pressure homogenization, with a pressure of 300-700 bar, to obtain the composite nanoemulsion.
2. The application according to claim 1, characterized in that: The poloxamer includes poloxamer 188.
3. The application according to claim 1 or 2, characterized in that: The composite nanoemulsion is added to drinking water or feed at a mass content of 9-30‰.
Citation Information
Patent Citations
Arachidonic acid-containing composition for preventing and treating liver disease
JP1993163142A
Feed additive for improving intestinal health of weaned kittens and preparation method therefor
WO2023077877A1
